L-carnitine Corrects Ammonia Metabolism in Hepatectomized Patients
NCT ID: NCT03021876
Last Updated: 2017-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
80 participants
INTERVENTIONAL
2016-04-30
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Carnitine Supplementation on Liver and Muscle
NCT03439917
Effect of Acetyl-L-carnitine on Chronic Pancreatitis
NCT02538146
Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
NCT01223742
Effect of Branch Chain Amino Acid Therapy on Sarcopenia in Children With Chronic Liver Disease.
NCT05093218
The Effect of Combination Therapy Amino Acid L-CARNITINE and Magnesium on Fatty Liver
NCT03319199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ordinary group
usual intake prior to liver surgery
usual intake
baseliner
carnitine group
treatment with oral L-carnitine, 1500 mg/body per day for 2 weeks prior to liver surgery
L-carnitine
treatment with oral L-carnitine, 1500 mg/body per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L-carnitine
treatment with oral L-carnitine, 1500 mg/body per day
usual intake
baseliner
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kochi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Takehiro Okabayashi
Division Manager
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kochi Health Sciences Center
Kochi, Kochi, Japan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Okabayashi T, Sui K, Mastumoto T, Iwata J, Morita S, Iiyama T, Shimada Y. l-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients. JPEN J Parenter Enteral Nutr. 2020 Jul;44(5):823-830. doi: 10.1002/jpen.1720. Epub 2019 Oct 9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LAMP study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.